✦ LIBER ✦

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

✍ Scribed by Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller

Book ID: 117301815
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 130 KB
Volume: 370
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(07)61445-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postoperative fondaparinux versus postop

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

✍ Alexander GG Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 89 KB

Extended duration rivaroxaban versus sho

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

✍ Ajay K Kakkar; Benjamin Brenner; Ola E Dahl; Bengt I Eriksson; Patrick Mouret; J 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 175 KB

Oral dabigatran etexilate vs. subcutaneo

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; N. ROSENCHER; A. A. KURTH; C. N. VAN DIJK; S. P. FRO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Postoperative fondaparinux versus preope

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

✍ Michael Rud Lassen; Kenneth A Bauer; Bengt I Eriksson; Alexander GG Turpie 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 95 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Dabigatran versus enoxaparin for prevent

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials

✍ R.J. Friedman; O.E. Dahl; N. Rosencher; J.A. Caprini; A.A. Kurth; C.W. Francis; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 664 KB